Director Shareholding

GlaxoSmithKline PLC 26 March 2002 Directors' Interests I give below details of changes in directors' interests in the Ordinary Shares of GlaxoSmithKline plc. 25 March 2002 Abacus (GW) Trustees Limited, as trustee of The Glaxo Wellcome Employee Trust ("the Trust"), transferred 3,400 Ordinary Shares in the Company to participants of the Glaxo Wellcome International Share Option Scheme. The Trust also sold 39,024 Ordinary Shares in the Company at £16.555 per share, 7,984 Ordinary Shares in the Company at £16.542 per share, 1,126 Ordinary Shares in the Company at £16.535 per share, and 1,205 Ordinary Shares in the Company at £16.715 per share. The Company was advised of these transactions on 26 March 2002. The Trust is a discretionary trust of which all employees or former employees of GlaxoSmithKline Services plc (formerly Glaxo Wellcome plc) and its subsidiaries are potential beneficiaries. Two of the Company's directors, Sir Richard Sykes and John Coombe are therefore interested in the shares held in the Trust from time to time in the same way as other employees or former employees of GlaxoSmithKline Services plc and its subsidiaries. S M Bicknell Company Secretary 26 March 2002 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings